Inhibrx Biosciences (INBX) Prepaid Assets (2023 - 2025)
Inhibrx Biosciences' (INBX) quarterly Prepaid Assets came in at $8.4 million in Q4 2025, up 2108.12% year-on-year from $382000.0 in Q4 2024, and up 1957.32% on a QoQ basis from $410000.0 in Q3 2025.
Inhibrx Biosciences (INBX) Prepaid Assets (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Prepaid Assets data on file, last reported at $8.4 million in Q4 2025.
- On a quarterly basis, Prepaid Assets rose 2108.12% year-over-year to $8.4 million in Q4 2025; TTM through Dec 2025 was $8.4 million, a 2108.12% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, up 2108.12% from the prior year.
- Prepaid Assets for Q4 2025 stood at $8.4 million, up from $410000.0 in the prior quarter.
- Over the last five years, Prepaid Assets for INBX reached as high as $8.4 million in Q4 2025 and fell as low as $269000.0 in Q1 2025.
- Historically, Prepaid Assets has averaged $1.5 million across 3 years, with a median of $396000.0 in 2024.
- On a YoY basis, Prepaid Assets climbed as much as 2108.12% in 2025 and fell as far as 70.7% in 2025.
- Year by year, Prepaid Assets stood at $366000.0 in 2023, then increased by 4.37% to $382000.0 in 2024, then surged by 2108.12% to $8.4 million in 2025.
- Per Business Quant data, the three most recent Prepaid Assets figures were $8.4 million in Q4 2025, $410000.0 in Q3 2025, and $283000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Inhibrx Biosciences | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.44 Mn |
| Sep 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 283,000.00 |
| Mar 31, 2025 | 269,000.00 |
| Dec 31, 2024 | 382,000.00 |
| Sep 30, 2024 | 748,000.00 |
| Jun 30, 2024 | 966,000.00 |
| Dec 31, 2023 | 366,000.00 |